Literature DB >> 30046890

[Rare diseases recognizable from blood smears].

J Hoffmann1, C Michel2, T Schindler2, E Wollmer2, A Neubauer2.   

Abstract

The examination of peripheral blood smears is not only essential for the differential diagnostics of hematological diseases but can also provide important indications for general internal diseases, infections, hereditary diseases and poisoning. By the systematic analysis of a blood smear for alterations to thrombocytes, erythrocytes and leukocytes, a blood smear investigation can make a decisive contribution to the formulation of a diagnosis. In this way evidence of rare diseases can also be gained when taking the corresponding clinical findings into consideration.

Entities:  

Keywords:  Anemia, sickle cell; Chédiak-Higashi syndrome; May-Hegglin anomaly; Pelger-Huët anomaly; Spherocytosis, hereditary

Mesh:

Year:  2018        PMID: 30046890     DOI: 10.1007/s00108-018-0467-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  Iron chelation therapy in the management of transfusion-related cardiac iron overload.

Authors:  Juliano Lara Fernandes
Journal:  Transfusion       Date:  2012-03-08       Impact factor: 3.157

Review 2.  Diagnosis from the blood smear.

Authors:  Barbara J Bain
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

3.  [General and special anaemia diagnostics].

Authors:  E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

4.  Familial Pelger-Huet Anomaly.

Authors:  Samir S Shah; Rupali S Parikh; Lakshmi P Vaswani; Rajeshree Divkar
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-25       Impact factor: 0.900

5.  Sickle Cell Disease.

Authors:  Frédéric B Piel; Martin H Steinberg; David C Rees
Journal:  N Engl J Med       Date:  2017-07-20       Impact factor: 91.245

6.  Historical hematology: May-Hegglin anomaly.

Authors:  Hidehiko Saito; Shinji Kunishima
Journal:  Am J Hematol       Date:  2008-04       Impact factor: 10.047

7.  Hereditary spherocytosis.

Authors:  Silverio Perrotta; Patrick G Gallagher; Narla Mohandas
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

8.  Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Authors:  C M Legendre; C Licht; P Muus; L A Greenbaum; S Babu; C Bedrosian; C Bingham; D J Cohen; Y Delmas; K Douglas; F Eitner; T Feldkamp; D Fouque; R R Furman; O Gaber; M Herthelius; M Hourmant; D Karpman; Y Lebranchu; C Mariat; J Menne; B Moulin; J Nürnberger; M Ogawa; G Remuzzi; T Richard; R Sberro-Soussan; B Severino; N S Sheerin; A Trivelli; L B Zimmerhackl; T Goodship; C Loirat
Journal:  N Engl J Med       Date:  2013-06-06       Impact factor: 91.245

Review 9.  Chediak-Higashi syndrome.

Authors:  Jerry Kaplan; Ivana De Domenico; Diane McVey Ward
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

Review 10.  The α-thalassemias.

Authors:  Frédéric B Piel; David J Weatherall
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.